Our data show that the increased β2M expression is mediated by the TGF-β1/Smad4/a-SMA pathway, resulting in alveolar epithelial cell EMT, alveolar wall/septal thickening, pulmonary fibrosis, and decreased DLCO values. This evidence concerns the gene TGFB1 and pulmonary fibrosis.